Singing May Be Better Than Breathing Exercises for Chronic Belching

Supragastric belching is not the kind of condition that gets a lot of attention, but for the people who live with it, it can be genuinely disruptive. Unlike ordinary belching that originates from the stomach, supragastric belching, or SGB, occurs when air is rapidly drawn into the esophagus and immediately expelled before it even reaches the stomach. It can happen dozens or even hundreds of times per day, often triggered or worsened by stress and anxiety, and it significantly impairs quality of life for those affected.

The standard first-line treatment recommended in clinical guidelines is diaphragmatic breathing, a technique that involves slow, controlled breathing from the diaphragm rather than the chest. It works for some patients, but it comes with a real problem: Many people find it tedious, repetitive and hard to sustain over time. Adherence suffers, and when adherence suffers, results follow.

A new randomized controlled trial, the results of which were published in Clinical Gastroenterology and Hepatology, conducted at two tertiary gastroenterology centers in China, set out to test whether structured singing therapy might offer a more effective and more engaging alternative. The results, published in 2025, were striking.

How Investigators Put It to the Test

Investigators enrolled 72 patients with SGB diagnosed according to Rome IV criteria, the gold standard diagnostic framework for functional gastrointestinal disorders. Participants were randomly assigned to either structured singing therapy or diaphragmatic breathing. The primary outcome was whether patients achieved at least a 50% reduction in belching severity on a standardized visual analogue scale. Secondary outcomes included quality of life, anxiety, depression and gastrointestinal symptom severity. Patients were assessed at the start of the study, immediately after the one-week treatment period and again at a one-month follow-up.

What the Data Showed

The singing therapy group outperformed the diaphragmatic breathing group by a substantial margin. Immediately after the one-week intervention, 72.2% of patients in the singing group met the threshold for meaningful improvement compared with 38.9% in the diaphragmatic breathing group.

At the one-month follow-up, 50% of singing therapy patients maintained that response compared with 30.6% of those in the diaphragmatic breathing group. Both differences were statistically significant.

Beyond the primary outcome, singing therapy also produced greater improvements in quality of life and belching symptom relief at the end of the treatment period. Importantly, its advantage over diaphragmatic breathing held up at the one-month mark, suggesting the benefits were not simply a short-term novelty effect.

Patients who responded to treatment also reported higher acceptability of the therapy, meaning they were more satisfied with it as an intervention. Statistical analysis confirmed that singing therapy, older age and higher baseline belching severity were all significant predictors of who was most likely to respond.

Engagement matters clinically. A treatment patients actually enjoy doing is a treatment they will stick with, and adherence is one of the most reliable predictors of long-term outcomes in any behavioral intervention.

What to Take Away From This

Supragastric belching is a real and underrecognized condition that deserves more clinical attention than it typically receives. This research suggests that structured singing therapy may be worth discussing with a gastroenterologist. It is low-risk and accessible, and now has meaningful clinical evidence behind it.

This was a single trial conducted over a relatively short period at two centers in China, so larger and longer studies are needed before singing therapy becomes a standard recommendation. But for patients looking for an engaging, effective and surprisingly pleasant alternative to diaphragmatic breathing, the evidence is genuinely encouraging.